Diligence memo · auto-generated · as of July 3, 2026
Doza Investments - Relox Medical, L.P.
Doza Investments - Relox Medical, L.P. looks under-valued against its niche peers and is active on financing cadence.
Businessfiled
Doza Investments - Relox Medical, L.P. operates in Pharmaceuticals, based in NAPLES.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Doza Investments - Relox Medical, L.P. has raised $2.7M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $2.7M on —.
Valuation (modeled)modeled
Provath models Doza Investments - Relox Medical, L.P. at approximately $4.5M (range $2.0M–$6.9M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.09× the median modeled value of Seed Pharmaceuticals companies (335 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
No dated round to assess.
Comparablesmixed
Capital scale ranks ahead of 31% of Pharmaceuticals peers (1613 compared).
Modeled value ranks above 7% of those peers.
Peoplefiled
1 named person on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.